Bank of America
LEXX icon

Bank of America’s Lexaria Bioscience LEXX Stock Holding History

Bank of America’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14
Closed -$126 – 6374
2025
Q4 		$126 Buy
14
+2
+17% +$28 ﹤0.01% 6786
2025
Q3 		$164 Buy
12
+1
+9% +$15 ﹤0.01% 7765
2025
Q2 		$146 Buy
11
+2
+22% +$34 ﹤0.01% 7902
2025
Q1 		$227 Buy
9
+1
+13% +$25 ﹤0.01% 7660
2024
Q4 		$265 Hold
8
– – ﹤0.01% 7531
2024
Q3 		$351 Buy
8
+2
+33% +$95 ﹤0.01% 7452
2024
Q2 		$267 Sell
6
-10
-63% -$450 ﹤0.01% 7493
2024
Q1 		$860 Buy
+16
New +$612 ﹤0.01% 7222
2021
Q2 		– Sell
-10
Closed -$1K – 7916
2021
Q1 		$1K Buy
+10
New +$879 ﹤0.01% 7316

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Bank of America's LEXX Position: Q1 2026 in Review

Bank of America sold out of Lexaria Bioscience (LEXX) in Q1 2026, closing a stake of 14 shares — an estimated $126 sold.

Bank of America first reported a position in LEXX in Q1 2021 and held it in 9 quarters. The position peaked at $1K in Q1 2021. 25 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Bank of America reported no remaining Lexaria Bioscience position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 14 Lexaria Bioscience shares in Q1 2026, an estimated $126.
  • Bank of America first reported a position in Lexaria Bioscience in Q1 2021 and held it in 9 quarters.
  • Bank of America's Lexaria Bioscience position peaked at $1K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.